CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE

CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE was reported 1964 times

CHLORPHENIRAMINE MALEATE AND DEXTROMETHORPHAN HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERENNIAL ALLERGY 1 0.0385
1 ADMINISTRATION SITE HYPERSENSITIVITY 1 0.0323
2 INFUSION SITE CYST 1 0.0312
3 BRONCHOALVEOLAR LAVAGE 1 0.0164
4 DRUG REHABILITATION 2 0.0143
5 EYE PENETRATION 1 0.0125
6 ILLOGICAL THINKING 2 0.0106
7 BLEEDING TIME ABNORMAL 1 0.0097
8 DRUG TITRATION 1 0.0064
9 STAB WOUND 2 0.0056
10 SENSORY LEVEL ABNORMAL 1 0.0044
11 CRIME 1 0.0038
12 SHOPLIFTING 1 0.0036
13 DECREASED EYE CONTACT 1 0.0033
14 PRESSURE OF SPEECH 2 0.0031
15 MENTAL RETARDATION 1 0.0028
16 GRANDIOSITY 1 0.0027
17 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
18 DRUG EFFECT DELAYED 12 0.0026
19 OESOPHAGEAL INJURY 1 0.0026
20 WALKING DISTANCE TEST ABNORMAL 1 0.0026
21 PRE-EXISTING DISEASE 1 0.0021
22 DRAINAGE 1 0.0020
23 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
24 OXYGEN CONSUMPTION DECREASED 1 0.0017
25 PRECANCEROUS CONDITION 1 0.0015
26 FEELING OF RELAXATION 1 0.0015
27 SUSPICIOUSNESS 1 0.0014
28 EXPIRED DRUG ADMINISTERED 7 0.0014
29 DRUG EFFECT DECREASED 74 0.0014
30 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
31 DIZZINESS EXERTIONAL 1 0.0013
32 DIAPHRAGMATIC DISORDER 1 0.0013
33 RENAL HAEMANGIOMA 1 0.0013
34 SLEEP TALKING 2 0.0012
35 DEAFNESS TRANSITORY 1 0.0012
36 EUPHORIC MOOD 12 0.0012
37 ALLERGIC SINUSITIS 1 0.0012
38 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
39 CLONUS 3 0.0011
40 PARTNER STRESS 1 0.0010
41 ANTISOCIAL BEHAVIOUR 1 0.0010
42 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
43 FOREIGN BODY IN THROAT 3 0.0010
44 PRODUCT NAME CONFUSION 1 0.0009
45 CARDIAC HYPERTROPHY 1 0.0009
46 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
47 HYPORESPONSIVE TO STIMULI 1 0.0009
48 POST-ACUTE COVID-19 SYNDROME 1 0.0008
49 LIP DISCOLOURATION 1 0.0008
50 HOSTILITY 2 0.0008
51 MUCOUS MEMBRANE DISORDER 1 0.0007
52 TENSION 4 0.0007
53 INTENTIONAL OVERDOSE 42 0.0007
54 RUBBER SENSITIVITY 1 0.0007
55 COAGULATION TIME PROLONGED 1 0.0006
56 PRODUCT DEPOSIT 1 0.0006
57 INAPPROPRIATE AFFECT 1 0.0006
58 SUBSTANCE USE DISORDER 2 0.0006
59 DRUG ABUSE 51 0.0006
60 ILLUSION 1 0.0006
61 INCREASED UPPER AIRWAY SECRETION 3 0.0006
62 HYPOPNOEA 2 0.0006
63 HYPERREFLEXIA 2 0.0006
64 APPARENT DEATH 2 0.0006
65 HOMICIDE 1 0.0005
66 TUNNEL VISION 1 0.0005
67 TRAUMATIC HAEMORRHAGE 1 0.0005
68 TRAUMATIC LUNG INJURY 1 0.0005
69 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
70 PSYCHIATRIC DECOMPENSATION 1 0.0005
71 MUCOSAL DRYNESS 1 0.0005
72 SEASONAL ALLERGY 7 0.0005
73 LIBIDO INCREASED 1 0.0005
74 EYELID PAIN 1 0.0005
75 PHYSICAL ASSAULT 1 0.0005
76 HAEMATOCRIT INCREASED 1 0.0004
77 GASTROINTESTINAL OBSTRUCTION 1 0.0004
78 CHOKING 8 0.0004
79 ACUTE PSYCHOSIS 1 0.0004
80 INFREQUENT BOWEL MOVEMENTS 1 0.0004
81 CATHETER SITE HAEMORRHAGE 1 0.0004
82 EYELID IRRITATION 1 0.0004
83 MYDRIASIS 5 0.0004
84 MEAN CELL VOLUME INCREASED 1 0.0004
85 BLOOD CHLORIDE DECREASED 1 0.0004
86 DELUSION 6 0.0004
87 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
88 NYSTAGMUS 2 0.0004
89 PRODUCT SIZE ISSUE 2 0.0004
90 RED BLOOD CELL COUNT INCREASED 1 0.0004
91 DRUG EFFECT INCOMPLETE 13 0.0004
92 JOINT LOCK 1 0.0004
93 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
94 SOMNOLENCE 69 0.0003
95 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
96 ENERGY INCREASED 2 0.0003
97 CARDIAC PACEMAKER INSERTION 2 0.0003
98 OVERDOSE 71 0.0003
99 NASAL DRYNESS 2 0.0003
100 DRUG EFFECT INCREASED 1 0.0003
101 SEROTONIN SYNDROME 6 0.0003
102 STUPOR 1 0.0003
103 INFUSION SITE PAIN 4 0.0003
104 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
105 CARDIAC FLUTTER 2 0.0003
106 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
107 OEDEMA MOUTH 1 0.0003
108 HALLUCINATION 23 0.0003
109 INFUSION SITE HAEMORRHAGE 1 0.0003
110 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
111 TACHYPHRENIA 1 0.0003
112 MICTURITION DISORDER 1 0.0003
113 FACIAL PARESIS 1 0.0003
114 ABNORMAL BEHAVIOUR 11 0.0003
115 HYPERTENSIVE CRISIS 3 0.0003
116 CATHETER SITE INFECTION 1 0.0003
117 UNEVALUABLE EVENT 20 0.0003
118 DERMATITIS CONTACT 3 0.0003
119 REHABILITATION THERAPY 1 0.0003
120 EPIGASTRIC DISCOMFORT 1 0.0003
121 DRUG SCREEN POSITIVE 2 0.0003
122 HYPERPHAGIA 1 0.0003
123 ACCIDENTAL OVERDOSE 9 0.0002
124 POISONING 3 0.0002
125 HALLUCINATIONS, MIXED 1 0.0002
126 PSYCHOTIC DISORDER 7 0.0002
127 DEVICE OPERATIONAL ISSUE 1 0.0002
128 TOOTH INJURY 1 0.0002
129 CATHETERISATION CARDIAC 1 0.0002
130 URINARY TRACT DISORDER 1 0.0002
131 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
132 HAEMOGLOBIN INCREASED 1 0.0002
133 EAR DISORDER 1 0.0002
134 ROSACEA 1 0.0002
135 SKIN TIGHTNESS 1 0.0002
136 SINUS TACHYCARDIA 3 0.0002
137 EXPIRED PRODUCT ADMINISTERED 7 0.0002
138 ENDOMETRIOSIS 1 0.0002
139 AFFECT LABILITY 2 0.0002
140 APHAGIA 1 0.0002
141 FINGER DEFORMITY 1 0.0002
142 DIZZINESS POSTURAL 2 0.0002
143 INCORRECT DOSAGE ADMINISTERED 1 0.0002
144 BREATH SOUNDS ABNORMAL 1 0.0002
145 HYPERVOLAEMIA 1 0.0002
146 PROTEIN URINE PRESENT 1 0.0002
147 DRY THROAT 2 0.0002
148 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
149 RESPIRATORY TRACT CONGESTION 3 0.0002
150 HALLUCINATION, AUDITORY 3 0.0002
151 NONSPECIFIC REACTION 1 0.0002
152 ASTHENOPIA 1 0.0002
153 DEAFNESS UNILATERAL 1 0.0002
154 PRODUCT LEAKAGE 1 0.0002
155 AGITATION 13 0.0002
156 PARANOIA 3 0.0002
157 PRODUCT LABEL CONFUSION 1 0.0002
158 COVID-19 PNEUMONIA 2 0.0002
159 DRUG ABUSER 1 0.0002
160 CARDIOMEGALY 2 0.0002
161 THINKING ABNORMAL 3 0.0002
162 PRE-EXISTING CONDITION IMPROVED 1 0.0002
163 INFUSION SITE SWELLING 1 0.0002
164 FEELING JITTERY 3 0.0002
165 SCREAMING 1 0.0002
166 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
167 THROAT IRRITATION 7 0.0002
168 INCOHERENT 1 0.0002
169 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
170 PLATELET COUNT INCREASED 2 0.0002
171 IMMUNE SYSTEM DISORDER 2 0.0002
172 BLOOD PRESSURE ABNORMAL 3 0.0002
173 BLOOD PRESSURE INCREASED 23 0.0002
174 DRUG TOXICITY 2 0.0001
175 PRODUCTIVE COUGH 7 0.0001
176 EYE MOVEMENT DISORDER 1 0.0001
177 DEPENDENCE 8 0.0001
178 RESPIRATION ABNORMAL 1 0.0001
179 ORAL DISCOMFORT 2 0.0001
180 APHONIA 2 0.0001
181 AGGRESSION 7 0.0001
182 CEREBRAL DISORDER 1 0.0001
183 FEELING DRUNK 1 0.0001
184 SNEEZING 3 0.0001
185 HEART RATE IRREGULAR 3 0.0001
186 HEART RATE INCREASED 13 0.0001
187 HYPERTHERMIA 1 0.0001
188 DRUG DEPENDENCE 21 0.0001
189 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
190 DRUG ADMINISTRATION ERROR 4 0.0001
191 FOOD ALLERGY 1 0.0001
192 APNOEA 1 0.0001
193 PELVIC FRACTURE 1 0.0001
194 HAEMORRHAGIC STROKE 1 0.0001
195 NASAL DISCOMFORT 1 0.0001
196 RENAL CYST 1 0.0001
197 LIVER INJURY 3 0.0001
198 AGEUSIA 3 0.0001
199 INFUSION SITE ERYTHEMA 1 0.0001
200 UNRESPONSIVE TO STIMULI 3 0.0001
201 BLOOD MAGNESIUM DECREASED 1 0.0001
202 MUSCLE STRAIN 1 0.0001
203 GROIN PAIN 1 0.0001
204 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
205 RESPIRATORY RATE INCREASED 1 0.0001
206 THERAPY NON-RESPONDER 5 0.0001
207 ANAL INCONTINENCE 1 0.0001
208 ABNORMAL DREAMS 3 0.0001
209 RHINORRHOEA 7 0.0001
210 MENTAL STATUS CHANGES 3 0.0001
211 PERSONALITY CHANGE 1 0.0001
212 DIARRHOEA HAEMORRHAGIC 1 0.0001
213 DYSARTHRIA 4 0.0001
214 SPINAL DISORDER 1 0.0001
215 SPUTUM DISCOLOURED 1 0.0001
216 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
217 VITAMIN D DEFICIENCY 1 0.0001
218 HOSPICE CARE 1 0.0001
219 SINUS DISORDER 2 0.0001
220 INABILITY TO AFFORD MEDICATION 1 0.0001
221 PRODUCT PHYSICAL ISSUE 2 0.0001
222 EAR DISCOMFORT 1 0.0001
223 VENTRICULAR EXTRASYSTOLES 1 0.0001
224 SWOLLEN TONGUE 3 0.0001
225 PULMONARY HYPERTENSION 2 0.0001
226 NERVOUSNESS 5 0.0001
227 INTENTIONAL DRUG MISUSE 2 0.0001
228 WEIGHT FLUCTUATION 1 0.0001
229 INJECTION SITE DISCOMFORT 1 0.0001
230 RENAL PAIN 1 0.0001
231 RETCHING 2 0.0001
232 POOR QUALITY SLEEP 2 0.0001
233 FAECES DISCOLOURED 2 0.0001
234 BIPOLAR DISORDER 1 0.0001
235 INTENTIONAL PRODUCT MISUSE 8 0.0001
236 EYE DISORDER 3 0.0001
237 PERICARDIAL EFFUSION 2 0.0001
238 DELIRIUM 3 0.0001
239 SPINAL PAIN 1 0.0001
240 DRUG INEFFECTIVE 111 0.0001
241 MYOCLONUS 1 0.0001
242 MUSCLE RIGIDITY 1 0.0001
243 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
244 SUICIDE ATTEMPT 5 0.0001
245 NOCTURIA 1 0.0001
246 SCHIZOPHRENIA 1 0.0001
247 NO THERAPEUTIC RESPONSE 1 0.0001
248 SYNCOPE 8 0.0001
249 SECRETION DISCHARGE 1 0.0001
250 EXPOSURE VIA SKIN CONTACT 2 0.0001
251 SPEECH DISORDER 4 0.0001
252 INCORRECT PRODUCT STORAGE 1 0.0001
253 DISORIENTATION 3 0.0001
254 OROPHARYNGEAL PAIN 7 0.0001
255 ADVERSE REACTION 1 0.0001
256 INSOMNIA 20 0.0001
257 PRODUCT USE ISSUE 14 0.0001
258 FEAR 2 0.0001
259 PRODUCT TASTE ABNORMAL 1 0.0001
260 FEELING ABNORMAL 17 0.0001
261 PAIN IN JAW 2 0.0001
262 HYPERHIDROSIS 9 0.0001
263 ANOSMIA 1 0.0001
264 APATHY 1 0.0001
265 NASAL CONGESTION 4 0.0001
266 EPISTAXIS 5 0.0001
267 IRRITABILITY 4 0.0001
268 DEVICE FAILURE 1 0.0001
269 INSURANCE ISSUE 1 0.0001
270 BRAIN FOG 1 0.0001
271 PRODUCT USE COMPLAINT 1 0.0001
272 COMA 3 0.0001
273 SCIATICA 1 0.0001
274 LOSS OF CONSCIOUSNESS 8 0.0001
275 MANIA 1 0.0001
276 PHOTOSENSITIVITY REACTION 1 0.0001
277 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
278 LIP SWELLING 2 0.0001
279 URINARY RETENTION 2 0.0001
280 PALPITATIONS 7 0.0001
281 CIRCULATORY COLLAPSE 1 0.0001
282 NIGHTMARE 2 0.0001
283 ORTHOSTATIC HYPOTENSION 1 0.0001
284 LOCAL SWELLING 1 0.0001
285 HYPOXIA 2 0.0001
286 COLD SWEAT 1 0.0001
287 DRUG ERUPTION 1 0.0001
288 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
289 GOUT 1 0.0001
290 TOOTHACHE 1 0.0001
291 OSTEOMYELITIS 1 0.0001
292 RESTLESSNESS 2 0.0001
293 DYSURIA 2 0.0001
294 HEPATIC STEATOSIS 1 0.0001
295 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
296 BLOOD GLUCOSE INCREASED 10 0.0001
297 BLOOD SODIUM DECREASED 1 0.0001
298 CHRONIC KIDNEY DISEASE 4 0.0001
299 CONDITION AGGRAVATED 16 0.0001
300 PROTEINURIA 1 0.0001
301 CONVULSION 3 0.0001
302 SLEEP APNOEA SYNDROME 1 0.0001
303 POST PROCEDURAL COMPLICATION 1 0.0001
304 DRUG PRESCRIBING ERROR 1 0.0001
305 HERNIA 1 0.0001
306 DYSPHONIA 3 0.0001
307 ORAL HERPES 1 0.0001
308 KIDNEY INFECTION 1 0.0001
309 INTENTIONAL SELF-INJURY 1 0.0000
310 EXTRA DOSE ADMINISTERED 2 0.0000
311 TASTE DISORDER 1 0.0000
312 FEELING HOT 3 0.0000
313 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
314 INCORRECT DOSE ADMINISTERED 11 0.0000
315 COMPLETED SUICIDE 4 0.0000
316 POLLAKIURIA 2 0.0000
317 ROAD TRAFFIC ACCIDENT 2 0.0000
318 TOXICITY TO VARIOUS AGENTS 8 0.0000
319 HALLUCINATION, VISUAL 1 0.0000
320 RECTAL HAEMORRHAGE 2 0.0000
321 SKIN CANCER 1 0.0000
322 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
323 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
324 MENTAL DISORDER 2 0.0000
325 BLOOD PRESSURE DECREASED 3 0.0000
326 TACHYCARDIA 4 0.0000
327 RASH PAPULAR 1 0.0000
328 ADVERSE DRUG REACTION 4 0.0000
329 CHROMATURIA 1 0.0000
330 DIZZINESS 22 0.0000
331 TINNITUS 2 0.0000
332 SKIN DISCOLOURATION 2 0.0000
333 NASOPHARYNGITIS 8 0.0000
334 CONFUSIONAL STATE 7 0.0000
335 PRODUCT PRESCRIBING ERROR 1 0.0000
336 MENTAL IMPAIRMENT 1 0.0000
337 PRESYNCOPE 1 0.0000
338 LUNG DISORDER 2 0.0000
339 ABASIA 1 0.0000
340 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
341 FLUID RETENTION 2 0.0000
342 COUGH 11 0.0000
343 RASH GENERALISED 1 0.0000
344 RESPIRATORY TRACT INFECTION 1 0.0000
345 SEDATION 1 0.0000
346 EAR INFECTION 1 0.0000
347 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
348 FREQUENT BOWEL MOVEMENTS 1 0.0000
349 OEDEMA 2 0.0000
350 PALLOR 1 0.0000
351 MOOD ALTERED 1 0.0000
352 TREATMENT NONCOMPLIANCE 2 0.0000
353 MEMORY IMPAIRMENT 5 0.0000
354 RESPIRATORY ARREST 1 0.0000
355 PROCEDURAL PAIN 1 0.0000
356 FEELING COLD 1 0.0000
357 NECK PAIN 2 0.0000
358 WOUND 1 0.0000
359 BLISTER 2 0.0000
360 OXYGEN SATURATION DECREASED 2 0.0000
361 OFF LABEL USE 31 0.0000
362 ASTHMA 4 0.0000
363 HYPERSOMNIA 1 0.0000
364 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
365 DYSSTASIA 1 0.0000
366 COVID-19 6 0.0000
367 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
368 URINARY INCONTINENCE 1 0.0000
369 RENAL INJURY 1 0.0000
370 DYSPNOEA 19 0.0000
371 LACRIMATION INCREASED 1 0.0000
372 HYPERTENSION 7 0.0000
373 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
374 ADVERSE EVENT 3 0.0000
375 HOSPITALISATION 5 0.0000
376 PERIPHERAL SWELLING 5 0.0000
377 EMOTIONAL DISORDER 1 0.0000
378 LIMB DISCOMFORT 1 0.0000
379 HEAD INJURY 1 0.0000
380 MOVEMENT DISORDER 1 0.0000
381 NIGHT SWEATS 1 0.0000
382 DYSPEPSIA 3 0.0000
383 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
384 TREMOR 5 0.0000
385 INJECTION SITE PRURITUS 2 0.0000
386 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
387 DIARRHOEA 19 0.0000
388 SINUSITIS 3 0.0000
389 ILLNESS 3 0.0000
390 HEADACHE 18 0.0000
391 SLEEP DISORDER 2 0.0000
392 CRYING 1 0.0000
393 INJECTION SITE MASS 1 0.0000
394 BRONCHITIS 2 0.0000
395 ASTHENIA 10 0.0000
396 DYSPNOEA EXERTIONAL 1 0.0000
397 INTESTINAL OBSTRUCTION 1 0.0000
398 DIABETES MELLITUS 2 0.0000
399 INJECTION SITE SWELLING 2 0.0000
400 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
401 SEIZURE 3 0.0000
402 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
403 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
404 DRY MOUTH 2 0.0000
405 DYSKINESIA 1 0.0000
406 ABDOMINAL PAIN UPPER 5 0.0000
407 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
408 NAUSEA 19 0.0000
409 RHABDOMYOLYSIS 1 0.0000
410 CARDIO-RESPIRATORY ARREST 1 0.0000
411 WITHDRAWAL SYNDROME 1 0.0000
412 PRODUCT DOSE OMISSION ISSUE 7 0.0000
413 DEVICE DISLOCATION 1 0.0000
414 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
415 RENAL FAILURE 3 0.0000
416 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
417 NEPHROLITHIASIS 1 0.0000
418 HYPOKALAEMIA 1 0.0000
419 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
420 CHEST PAIN 4 0.0000
421 WEIGHT DECREASED 6 0.0000
422 COGNITIVE DISORDER 1 0.0000
423 CARDIAC DISORDER 2 0.0000
424 ARRHYTHMIA 1 0.0000
425 FALL 7 0.0000
426 DISEASE RECURRENCE 1 0.0000
427 RASH ERYTHEMATOUS 1 0.0000
428 MULTIPLE SCLEROSIS 1 0.0000
429 ATRIAL FIBRILLATION 2 0.0000
430 MALAISE 9 0.0000
431 DRY EYE 1 0.0000
432 HYPOTENSION 4 0.0000
433 CELLULITIS 1 0.0000
434 FLUSHING 2 0.0000
435 CHEST DISCOMFORT 2 0.0000
436 THERAPY CESSATION 1 0.0000
437 VOMITING 9 0.0000
438 RASH PRURITIC 1 0.0000
439 HAEMATOCHEZIA 1 0.0000
440 FATIGUE 14 0.0000
441 INFLUENZA 2 0.0000
442 ABDOMINAL DISCOMFORT 3 0.0000
443 ANXIETY 5 0.0000
444 LETHARGY 1 0.0000
445 EYE IRRITATION 1 0.0000
446 PRODUCT SUBSTITUTION ISSUE 1 0.0000
447 DECREASED APPETITE 4 0.0000
448 BACK PAIN 4 0.0000
449 CHILLS 2 0.0000
450 SURGERY 1 0.0000
451 ILL-DEFINED DISORDER 1 0.0000
452 PLEURAL EFFUSION 1 0.0000
453 DISCOMFORT 1 0.0000
454 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
455 GAIT DISTURBANCE 3 0.0000
456 PNEUMONIA 5 0.0000
457 AMNESIA 1 0.0000
458 SWELLING FACE 1 0.0000
459 ALOPECIA 3 0.0000
460 DEHYDRATION 2 0.0000
461 HEPATIC ENZYME INCREASED 1 0.0000
462 VISION BLURRED 2 0.0000
463 BURNING SENSATION 1 0.0000
464 INJURY 1 0.0000
465 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
466 MOBILITY DECREASED 1 0.0000
467 RASH 6 0.0000
468 UNDERDOSE 1 0.0000
469 PAIN IN EXTREMITY 4 0.0000
470 DYSGEUSIA 1 0.0000
471 HYPOAESTHESIA 2 0.0000
472 ACUTE KIDNEY INJURY 2 0.0000
473 ARTHRITIS 1 0.0000
474 PARAESTHESIA 2 0.0000
475 DRUG INTERACTION 2 0.0000
476 INJECTION SITE HAEMORRHAGE 1 0.0000
477 PROSTATE CANCER 1 0.0000
478 CARDIAC ARREST 1 0.0000
479 URTICARIA 2 0.0000
480 CEREBROVASCULAR ACCIDENT 2 0.0000
481 MYALGIA 2 0.0000
482 BALANCE DISORDER 1 0.0000
483 MUSCLE SPASMS 2 0.0000
484 HYPERSENSITIVITY 2 0.0000
485 SWELLING 1 0.0000
486 DYSPHAGIA 1 0.0000
487 NEUROPATHY PERIPHERAL 1 0.0000
488 ANAEMIA 2 0.0000
489 MIGRAINE 1 0.0000
490 CONTUSION 1 0.0000
491 ERYTHEMA 2 0.0000
492 HAEMORRHAGE 1 0.0000
493 DEATH 8 0.0000
494 WEIGHT INCREASED 2 0.0000
495 DEPRESSION 2 0.0000
496 PYREXIA 3 0.0000
497 OEDEMA PERIPHERAL 1 0.0000
498 VISUAL IMPAIRMENT 1 0.0000
499 INJECTION SITE ERYTHEMA 1 0.0000
500 DRY SKIN 1 0.0000
501 PAIN 4 0.0000
502 MYOCARDIAL INFARCTION 1 0.0000
503 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
504 ARTHRALGIA 2 0.0000
505 CONSTIPATION 1 0.0000
506 ABDOMINAL PAIN 1 0.0000
507 PRURITUS 1 0.0000